Trial Innovation Network

The Trial Innovation Network is a collaborative national network focused on operational innovation, excellence, and collaboration, that leverages the expertise and resources of the CTSA Program. It was developed to address critical roadblocks in clinical trials and accelerate the translation of novel interventions into life-saving therapies. The goal of the Trial Innovation Network is to be a national laboratory to study, understand, and innovate the process of conducting clinical trials.

Learn More About the Trial Innovation Network

Trial Innovation Network Hub Liaison Team

The Trial Innovation Network Hub Liaison Team at the Irving Institute helps Columbia University Irving Medical Center (CUIMC) clinical trialists and investigators develop, fund, and implement clinical trials in the most efficient manner.

As key partners of the Trial Innovation Network, our liaison team plays an integral role by:

  • Encouraging faculty and investigators to generate ideas for trials
  • Providing input before protocols are submitted to the network and to NIH for funding
  • Recognizing the essential contributions and efforts of local teams in executing multi-center clinical trials
  • Creating a culture in which key stakeholders play unique and important roles, and help to build a national system to conduct clinical trials better, faster, and more cost-effectively


The Trial Innovation Network Hub Liaison Team provides support through:

Hub Liaison Team

  • Mitchell Elkind, MD

    Medical Director

    Headshot of Mitchell Elkind.
  • Soumitra Sengupta, PhD

    Director of Informatics

    Headshot of Soumitra Sengupta.
  • Linda Busacca

    Project Manager

  • Helen Kim, PharmD

    Contract Specialist

  • Rudi Odeh-Ramadan, PharmD

    Contract Specialist

  • Tasha Smith

    IRB Specialist